Network Pharmacology and Molecular Docking Study of Yupingfeng Powder in the Treatment of Allergic Diseases

Abstract

Objective. To explore the potential mechanisms of Yupingfeng Powder (YPFP) in the treatment of allergic diseases by using network pharmacology and molecular docking technology. Methods. The active components and targets of YPFP were screened by the TCMSP database. The targets associated with atopic dermatitis, asthma, allergic rhinitis, and food allergy were obtained from GeneCards and OMIM databases, respectively. The intersection of the above disease-related targets was identified as allergy-related targets. Then, allergy-related targets and YPFP-related targets were crossed to obtain the potential targets of YPFP for allergy treatment. A protein-protein-interaction (PPI) network and a drug-target-disease topology network were constructed to screen hub targets and key ingredients. Next, GO and KEGG pathway enrichment analyses were performed separately on the potential targets and hub targets to identify the biological processes and signaling pathways involved. Finally, molecular docking was conducted to verify the binding affinity between key ingredients and hub targets. Results. In this study, 45 active ingredients were identified from YPFP, and 48 allergy-related targets were predicted by network pharmacology. IL6, TNF, IL1B, PTGS2, CXCL8, JUN, CCL2, IL10, IFNG, and IL4 were screened as hub targets by the PPI network. However, quercetin, kaempferol, wogonin, formononetin, and 7-O-methylisomucronulatol were identified as key ingredients by the drug-target-disease topological network. GO and KEGG pathway enrichment analysis indicated that the therapeutic effect of YPFP on allergy involved multiple biological processes and signaling pathways, including positive regulation of fever generation, positive regulation of neuroinflammatory response, vascular endothelial growth factor production, negative regulation of cytokine production involved in immune response, positive regulation of mononuclear cell migration, type 2 immune response, and negative regulation of lipid storage. Molecular docking verified that all the key ingredients had good binding affinity with hub targets. Conclusion. This study revealed the key ingredients, hub targets, and potential mechanisms of YPFP antiallergy, and these data can provide some theoretical basis for subsequent allergy treatment and drug development.

Effects of Yu-Ping-Feng polysaccharides on animal growth performance and immune function: a review

“…Furthermore, they exhibit antibacterial, antiviral, and antioxidative stress properties (13). Besides, Yu-Ping-Feng prescription has been confirmed to have certain therapeutic effects on respiratory system diseases such as respiratory tract infections and asthma, immunodeficiency diseases, as well as allergic diseases (14)(15)(16)(17)(18)(19). To date, only a handful of mild to moderate adverse reactions have been reported due to the use of the Yu-Ping-Feng prescription.…”

Network pharmacology analysis of Huangqi reveals quercetin as a therapeutic for allergic rhinitis via the RELA-regulated IFNG/IRF1 axis response

“…For example, the possible therapeutic effect of acupuncture for AR treatment has been reported in numerous studies (Sun et al, 2016, Shou et al, 2020. The e ciency of herbal medicines from TCM in the treatment of AR has also been reported, suggesting the importance of developing new TCM drugs for AR (Yang et al, 2021, Qu et al, 2022.…”